Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.
Administration, Oral
Adolescent
Adult
Anti-Bacterial Agents
/ administration & dosage
Biodiversity
Ciprofloxacin
/ administration & dosage
Feces
/ microbiology
Gastrointestinal Microbiome
/ drug effects
Healthy Volunteers
Humans
Male
Metronidazole
/ administration & dosage
Time Factors
Vancomycin
/ administration & dosage
Young Adult
Journal
The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617
Informations de publication
Date de publication:
01 03 2019
01 03 2019
Historique:
received:
29
08
2018
revised:
09
10
2018
accepted:
17
10
2018
pubmed:
13
11
2018
medline:
4
6
2020
entrez:
13
11
2018
Statut:
ppublish
Résumé
The impact of combination antibiotic therapy on the composition of the intestinal microbiota remains ill-defined. We aimed to assess the effect of a 1 week antibiotic regimen on the intestinal microbiota of healthy humans for a period of up to 31 months. Thirteen healthy adult men received either no treatment or oral broad-spectrum antibiotics (ciprofloxacin, vancomycin and metronidazole) for 7 days. At four timepoints (prior to treatment, on day 9, day 49 and 8-31 months later) faecal samples were collected and analysed using 16S RNA gene sequencing. The short-term impact of broad-spectrum antibiotics on the gut microbiota was profound, with a loss of diversity and drastic shifts in community composition. In addition, antibiotics significantly reduced the abundance of bacterial taxa with important metabolic functions, such as the production of butyrate. The microbiota showed a remarkable return towards baseline after 8-31 months, but community composition often remained altered from its initial state. These findings suggest that combined treatment with vancomycin, ciprofloxacin and metronidazole has a profound and long-lasting effect on microbiota composition, the consequences of which remain largely unknown.
Identifiants
pubmed: 30418539
pii: 5173727
doi: 10.1093/jac/dky471
doi:
Substances chimiques
Anti-Bacterial Agents
0
Metronidazole
140QMO216E
Ciprofloxacin
5E8K9I0O4U
Vancomycin
6Q205EH1VU
Banques de données
ClinicalTrials.gov
['NCT02127749']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
782-786Informations de copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.